: (A) The number of viable BCR-ABL1-mutated KCL22 T315I cells remaining after 72 h treatment with IB were counted by Trypan Blue dye exclusion method and normalized to the untreated control (100%) and (B) stained with Annexin V and propidium iodide to assess apoptotic response to the drug by flow cytometry. Imatinib (IM, 10 µM) and ponatinib (PON, 100 nM) were used as 'negative' and 'positive' controls, respectively (A and B; n = 1, duplicate wells). (C) Illustrative flow cytometry dot plots of KCL22 T315I cell response to IB, IM, or PON after 72 h.
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